February 27, 2025
aXichem AB (publ) Bokslutskommuniké, januari – december 2024
aXichems utveckling under perioden 2024-01-01—2024-12-31 I denna delårsrapport presenteras koncernen
Read the article here
We create value.
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.
AXICHEM A
(AXIC A)
1.255
SEK
-0.01 / -0.79%
High
1.26
Low
1.085
Volume
21016
Turnover
23585.765
April 17, 2025 12:59:41
Financial Reports
February 27, 2025
aXichem AB (publ) Year End Report, January – December 2024
aXichem’s development during the period 2024-01-01—2024-12-31 In this interim report,
Read the article here
Financial Calendar
Year-end report 2024 - 27 February 2025
Q1 Report, Jan – March 2025 - 22 May 2025
Annual Report 2024 - 28 May 2025
Annual General Meeting - 18 June 2025
Q2 Report, Jan – June 2025 - 28 August 2025
Q3 Report, Jan – Sept 2025 - 28 November 2025
Year End Report 2025 - 26 February 2026
Press releases
April 16, 2025
aXichem utser Erik Lager till Chief Operating Officer, för att möta tillväxtfasens ökade behov av en kvalitetssäkrad leveransprocess
aXichem AB (publ), (aXichem), som utvecklar naturanaloga fodertillsatser och kosttillskottsingredienser,
Read the article here
April 16, 2025
aXichem appoints Erik Lager as Chief Operating Officer, to meet the growth phase’s increased need for a quality-assured delivery process
aXichem AB (publ), (aXichem), developer of innovative natural analogue feed
Read the article here
March 18, 2025
aXichem upptar kreditfacilitet med stöd från EIF, för fortsatt etablering av aXiphen i Brasilien
aXichem AB (publ), (aXichem), som utvecklar naturanaloga fodertillsatser och kosttillskottsingredienser,
Read the article here
March 18, 2025
aXichem takes up credit facility with support from EIF, for continued establishment of aXiphen in Brazil
aXichem AB (publ), (aXichem), developer of innovative natural analogue feed
Read the article here
March 05, 2025
aXichem meddelar preliminära resultat från CrossFit Performance-studie med aXivite, indikerande avsevärd förbättring av uthållighet och återhämtning
aXichem AB (publ), (aXichem), som utvecklar innovativa naturanaloga fodertillsatser och
Read the article here
March 05, 2025
aXichem Announces Preliminary Findings from CrossFit Performance Study with aXivite, Indicating Unmatched Endurance and Recovery Gains
aXichem AB (publ), (aXichem), the developer of innovative natural analogue
Read the article here
February 27, 2025
aXichem AB (publ) Bokslutskommuniké, januari – december 2024
aXichems utveckling under perioden 2024-01-01—2024-12-31 I denna delårsrapport presenteras koncernen
Read the article here
February 27, 2025
aXichem AB (publ) Year End Report, January – December 2024
aXichem’s development during the period 2024-01-01—2024-12-31 In this interim report,
Read the article here
February 25, 2025
aXichem’s CEO Torsten Helsing Presents the Year End Report 2024 in a Live Web Conference
aXichem AB (publ), publishes its Year End Report for 2024
Read the article here
February 25, 2025
aXichems VD Torsten Helsing presenterar bokslutskommuniké 2024 i en direktsänd webbkonferens
aXichem AB (publ), offentliggör sin bokslutskommuniké för 2024 torsdagen den
Read the article here
February 12, 2025
aXichem erhåller order från Chr. Olesen avseende aXiphen till ett värde av cirka 7 miljoner kronor
aXichem AB (publ), (aXichem), som utvecklar som utvecklar naturanaloga fodertillsatser
Read the article here
February 12, 2025
aXichem receives order from Chr. Olesen regarding aXiphen to a value of approximately SEK 7 million
aXichem AB (publ), (aXichem), the developer of innovative natural analogue
Read the article here
February 04, 2025
aXichem uppdaterar status för komplettering av Feed Additive-ansökan i EU för phenylcapsaicin
aXichem AB (publ), som utvecklar naturanaloga foder- och kosttillskottsingredienser, meddelar
Read the article here
February 04, 2025
aXichem updates status regarding completion of Feed Additive application in the EU for phenylcapsaicin
aXichem AB (publ), developer of innovative natural analogue feed additives
Read the article here
Commissioned Research
Company description
We draw from the genius of nature and respect nature in return.
aXichem Bolagsbeskrivning 131121
PDF 1.28 MB
Certified Advisor
Västra Hamnen Corporate Finance
Jungmansgatan 12
211 11 Malmö
General Meetings Archive
Investor Structure
aXichem’s ten largest owners according to the shareholders’ register kept by Euroclear as of 2024-12-31.
Total number of shares: 59 114 905.
| Name | Participating interest (%) |
| LMK-bolagen | 16,4 |
| Nordnet Pensionsförsäkring AB | 7,82 |
| Manakin Ltd | 6,14 |
| Avanza Pension | 5,61 |
| Pierre Sahlstrand | 3,95 |
| Aksjesel. Arbejdenes Landsbank | 3,37 |
| Christian Månsson | 2,89 |
| Sydbank | 2,1 |
| Anders Walldov | 1,77 |
| Hans Sköld | 1,07 |
Investor enquiries
Subscribe to information from aXichem